Breaking News

Capsugel Expands Late-Stage Inhalation Development Capabilities

Adds Harro Hӧfliger Modu-C MS encapsulation unit at its Bend, OR facility

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Capsugel has expanded its late-stage inhalation capabilities for dry powder inhalation (DPI) concepts through late-stage clinical trial and commercial production. The company has completed installation and validation of a new Harro Hӧfliger Modu-C MS encapsulation unit at its Bend, OR facility that includes specialized drum-dosing technology for use in DPI development projects utilizing spray-dry processing.   “Drug delivery via the lung is becoming an increasingly viable treatment optio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters